Compare METCB & CMPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | METCB | CMPS |
|---|---|---|
| Founded | 2015 | 2020 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Coal Mining | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 727.7M | 662.5M |
| IPO Year | N/A | 2020 |
| Metric | METCB | CMPS |
|---|---|---|
| Price | $12.55 | $7.79 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 8 |
| Target Price | ★ $38.69 | $16.43 |
| AVG Volume (30 Days) | 83.5K | ★ 1.1M |
| Earning Date | 10-27-2025 | 02-26-2026 |
| Dividend Yield | ★ 2.97% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $579,503,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $19.85 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.86 | $2.25 |
| 52 Week High | $21.80 | $7.15 |
| Indicator | METCB | CMPS |
|---|---|---|
| Relative Strength Index (RSI) | 54.02 | 70.16 |
| Support Level | $11.49 | $6.27 |
| Resistance Level | $12.69 | $7.14 |
| Average True Range (ATR) | 0.76 | 0.42 |
| MACD | 0.31 | 0.06 |
| Stochastic Oscillator | 93.30 | 93.07 |
Ramaco Resources Inc is a United States-based company that operates as a pure-play metallurgical coal company with operations in southern West Virginia and southwestern Virginia. Its portfolio includes high-quality metallurgical coal reserves & resources, with a focus on properties such as Elk Creek, Berwind, Knox Creek, and Maben. These properties are strategically located to serve North American blast furnace steel mills and coke plants, as well as international metallurgical coal consumers. Additionally, the company controls mineral deposits in Sheridan, Wyoming, exploring potential opportunities in rare earth elements and coal-to-carbon-based products. Operations are concentrated in the Appalachian basin, with active mines at Elk Creek, Berwind, Knox Creek, and Maben mining complexes.
Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of major depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360.